Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Accession Number
DB00874  (APRD01005)
Small Molecule
Approved, Investigational, Vet approved

An expectorant that also has some muscle relaxing action. It is used in many cough preparations.

  • Glyceryl guaiacolate
  • Guaifenesin
  • Guaifenesina
  • guaiphenesin
Product Images
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
7 Select Mucus ReliefTablet, extended release600 mg/1Oral7 Eleven2014-10-262017-06-07Us
Adult TussinSyrup100 mg/5mLOralRite Aid2013-09-212015-10-15Us
Adult Tussin Chest CongestionSolution200 mg/10mLOralHyvee1997-06-25Not applicableUs
Air PowerTablet200 mg/1OralSchwabe North America, Inc2003-05-19Not applicableUs
Air-powerTablet200 mgOralEnzymatic Therapy, Inc.1997-03-202002-08-08Canada
AkinSolution100 mg/5mLOralSouthern Sales & Service, Inc.2015-01-01Not applicableUs
AuroMucus - Childrens Chest CongestionSolution100 mg/5mLOralAurohealth LLC2015-08-24Not applicableUs
Aurotussin Mucus plus Chest Congestion (ORIGINAL)Liquid200 mg/10mLOralAurohealth LLC2015-06-26Not applicableUs
Balminil ExpectorantSyrup100 mgOralTeva1979-12-31Not applicableCanada
Balminil Expectorant (sucrose Free)Syrup100 mgOralTeva1979-12-31Not applicableCanada
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
7 select Tussin DMGuaifenesin (200 mg/10mL) + Dextromethorphan hydrobromide monohydrate (20 mg/10mL)SolutionOral7 Eleven2016-05-31Not applicableUs
Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine HydrochlorideGuaifenesin (100 mg/1) + Acetaminophen (325 mg/1) + Dextromethorphan hydrobromide monohydrate (10 mg/1) + Phenylephrine hydrochloride (5 mg/1)Tablet, coatedOralAAA Pharmaceutical, Inc.2012-12-22Not applicableUs
Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine HydrochlorideGuaifenesin (200 mg/1) + Acetaminophen (325 mg/1) + Dextromethorphan hydrobromide monohydrate (10 mg/1) + Phenylephrine hydrochloride (5 mg/1)Tablet, coatedOralAAA Pharmaceutical, Inc.2012-12-28Not applicableUs
Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine HydrochlorideGuaifenesin (200 mg/1) + Acetaminophen (325 mg/1) + Dextromethorphan hydrobromide monohydrate (10 mg/1) + Phenylephrine hydrochloride (5 mg/1)Tablet, coatedOralAAA Pharmaceutical, Inc.2012-12-28Not applicableUs
Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine HydrochlorideGuaifenesin (200 mg/1) + Acetaminophen (325 mg/1) + Dextromethorphan hydrobromide monohydrate (10 mg/1) + Phenylephrine hydrochloride (5 mg/1)Tablet, coatedOralAAA Pharmaceutical, Inc.2012-12-28Not applicableUs
Actidom DmxGuaifenesin (200 mg/5mL) + Dextromethorphan hydrobromide monohydrate (30 mg/5mL) + Phenylephrine hydrochloride (10 mg/5mL)SolutionOralActipharma, Inc2015-08-13Not applicableUs
ActinelGuaifenesin (200 mg/5mL) + Dextromethorphan hydrobromide monohydrate (15 mg/5mL) + Pseudoephedrine hydrochloride (30 mg/5mL)SolutionOralActipharma, Inc2014-09-24Not applicableUs
Actinel PediatricGuaifenesin (50 mg/5mL) + Dextromethorphan hydrobromide monohydrate (5 mg/5mL) + Pseudoephedrine hydrochloride (15 mg/5mL)SolutionOralActipharma, Inc2014-09-24Not applicableUs
Adult CF CoughGuaifenesin (100 mg/5mL) + Dextromethorphan hydrobromide monohydrate (10 mg/5mL) + Phenylephrine hydrochloride (5 mg/5mL)LiquidOralMeijer Distribution2006-08-112016-09-24Us
Adult Cold, Flu and Sore ThroatGuaifenesin (400 mg/20mL) + Acetaminophen (650 1/20mL) + Dextromethorphan hydrobromide monohydrate (20 mg/20mL) + Phenylephrine hydrochloride (10 mg/20mL)LiquidOralMc Kesson2012-12-01Not applicableUs
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
A-Tan 12X SuspensionGuaifenesin (100 mg/5mL) + Mepyramine tannate (30 mg/5mL) + Phenylephrine tannate (5 mg/5mL)SuspensionOralAmneal Pharmaceuticals2006-01-062008-12-05Us
Bromhist PDXGuaifenesin (50 mg/5mL) + Brompheniramine maleate (2 mg/5mL) + Dextromethorphan hydrobromide monohydrate (5 mg/5mL) + Phenylephrine hydrochloride (5 mg/5mL)SyrupOralCypress Pharmaceutical, Inc2006-04-282011-08-26Us
BrontussGuaifenesin (400 mg/1) + Dextromethorphan hydrobromide monohydrate (20 mg/1)TabletOralPortal Pharmaceuticals2010-05-032012-05-31Us
CarbatussGuaifenesin (100 mg/5mL) + Pentoxyverine citrate (20 mg/5mL) + Phenylephrine hydrochloride (10 mg/5mL)LiquidOralGm Pharmaceuticals2000-11-012007-11-01Us
CarbetaplexGuaifenesin (100 mg/5mL) + Pentoxyverine citrate (20 mg/5mL) + Phenylephrine hydrochloride (15 mg/5mL)LiquidOralBreckenridge Pharmaceutical, Inc.2004-04-012009-09-30Us51991 08320180906 25352 173omie
Codeine Phosphate GuaifenesinGuaifenesin (200 mg/5mL) + Codeine phosphate hemihydrate (10 mg/5mL)LiquidOralKylemore Pharmaceuticals, LLC2010-01-012012-11-30Us
CrantexGuaifenesin (100 mg/5mL) + Phenylephrine hydrochloride (7.5 mg/5mL)LiquidOralPhysicians Total Care, Inc.2004-03-172011-06-30Us
CrantexGuaifenesin (100 mg/5mL) + Phenylephrine hydrochloride (7.5 mg/5mL)LiquidOralBreckenridge Pharmaceutical, Inc.2002-02-012011-09-30Us
Dilex-G 400Guaifenesin (400 mg/1) + Dyphylline (200 mg/1)TabletOralPoly Pharmaceuticals2006-09-082011-09-30Us
Donatuss DCGuaifenesin (50 mg/5mL) + Dihydrocodeine bitartrate (7.5 mg/5mL) + Phenylephrine hydrochloride (7.5 mg/5mL)SyrupOralLaser Pharmaceuticals Llc2009-10-072013-09-30Us
International/Other Brands
Duratuss G / Ganidin (Cypress) / Hustosil (Kyoto Yakuhin) / Hytuss (Hyrex) / Robitussin (Wyeth) / Scot-tussin Expectorant / Sinumist-SR
CAS number
Average: 198.2158
Monoisotopic: 198.089208936
Chemical Formula
InChI Key



Used to assist the expectoration of phlegm from the airways in acute respiratory tract infections.

Associated Conditions

Guaifenesin is an expectorant which increases the output of phlegm (sputum) and bronchial secretions by reducing adhesiveness and surface tension. The increased flow of less viscous secretions promotes ciliary action and changes a dry, unproductive cough to one that is more productive and less frequent. By reducing the viscosity and adhesiveness of secretions, guaifenesin increases the efficacy of the mucociliary mechanism in removing accumulated secretions from the upper and lower airway.

Mechanism of action

Guaifenesin may act as an irritant to gastric vagal receptors, and recruit efferent parasympathetic reflexes that cause glandular exocytosis of a less viscous mucus mixture. Cough may be provoked. This combination may flush tenacious, congealed mucopurulent material from obstructed small airways and lead to a temporary improvement in dyspnea or the work of breathing.


Rapidly absorbed from the GI tract

Volume of distribution
Not Available
Protein binding
Not Available

Rapidly hydrolyzed (60% within seven hours) and then excreted in the urine, with beta-(2-methoxyphenoxy)-lactic acid as its major urinary metabolite.

Route of elimination
Not Available
Half life

1 hour

Not Available

LD50 1510 mg/kg (rat, oral)

Affected organisms
  • Humans and other mammals
Not Available
Pharmacogenomic Effects/ADRs
Not Available


Drug Interactions
Not Available
Food Interactions
  • Take with a full glass of water.
  • Take without regard to meals.


Synthesis Reference

Wilfred P. Shum, Harry Mazurek, Jian Chen, "Process for producing enantiomerically enriched guaifenesin." U.S. Patent US5495052, issued August, 1949.

General References
Not Available
External Links
Human Metabolome Database
PubChem Compound
PubChem Substance
RxList Drug Page Drug Page
PDRhealth Drug Page
ATC Codes
R05CA03 — Guaifenesin
AHFS Codes
  • 48:16.00 — Expectorants
FDA label
Download (394 KB)
Download (73.4 KB)

Clinical Trials

Clinical Trials
0Not Yet RecruitingDiagnosticAlzheimer's Disease (AD) / Mild Cognitive Impairment (MCI)1
0RecruitingDiagnosticStage IIB Esophageal Cancer / Stage IIB Esophageal Cancer AJCC v7 / Stage III Esophageal Cancer AJCC v7 / Stage IIIA Esophageal Cancer / Stage IIIA Esophageal Cancer AJCC v7 / Stage IIIB Esophageal Cancer / Stage IIIB Esophageal Cancer AJCC v7 / Stage IIIC Esophageal Cancer / Stage IIIC Esophageal Cancer AJCC v71
0RecruitingTreatmentCannabis Use Disorders1
1Active Not RecruitingTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1
1CompletedBasic ScienceHealthy Volunteers5
1CompletedOtherBioequivalence / Healthy Volunteers1
1CompletedSupportive CareHealthy Volunteers1
1CompletedTreatmentHealthy Volunteers1
1CompletedTreatmentMucociliary Clearance1
1, 2RecruitingTreatmentColorectal Cancers / Gastroesophageal Adenocarcinoma / Lung Cancer Non-Small Cell Cancer (NSCLC) / Transitional Cell Carcinoma / Tumors, Solid1
2CompletedTreatmentRespiratory Infections, Acute1
2CompletedTreatmentAcute Rhinitis1
2Enrolling by InvitationTreatmentAdenoid Hypertrophy1
2RecruitingTreatmentChronic Rhinitis1
2RecruitingTreatmentSevere Aplastic Anemia (SAA)1
2TerminatedTreatmentSickle Cell Disorders1
2WithdrawnTreatmentHuman Immunodeficiency Virus (HIV) Infections / Sinusitis1
2, 3CompletedTreatmentAcute Upper Respiratory Tract Infections1
3CompletedTreatmentAcute Nonlymphocytic Leukemia / Leukemia Acute Myeloid Leukemia (AML) / Leukemias1
3RecruitingTreatmentAbortion in First Trimester1
3Unknown StatusTreatmentViral Infections of the Upper Respiratory Tract1
4CompletedBasic ScienceHealthy Volunteers1
4CompletedPreventionAcute Upper Respiratory Track Infection1
4CompletedTreatmentAcute Rhinosinusitis / Respiratory Infections, Acute1
4CompletedTreatmentAcute maxillary sinusitis caused by M. catarrhalis / Bronchitis / Respiratory Infections, Acute1
4Not Yet RecruitingPreventionHerpes Simplex Virus Keratitis1
4Not Yet RecruitingTreatmentChronic heart failure with reduced ejection fraction (NYHA Class IV)1
Not AvailableCompletedNot AvailableBronchitis2
Not AvailableCompletedTreatmentFilamentary Keratitis1
Not AvailableCompletedTreatmentInfection NOS1
Not AvailableCompletedTreatmentPneumonia1
Not AvailableCompletedTreatmentUpper Back Pain1
Not AvailableRecruitingTreatmentPain, Chronic / Vulvodynia1


  • Reckitt benckiser inc
  • Adams Labs
  • Advanced Pharmaceutical Services Inc.
  • Alba Pharmacal
  • Aligon Pharmaceuticals Inc.
  • Allegis Pharmaceuticals
  • Ambi Pharmaceuticals Inc.
  • Amend
  • Amerisource Health Services Corp.
  • Anip Acquisition Co.
  • A-S Medication Solutions LLC
  • Atlantic Biologicals Corporation
  • Baroli
  • Bayer Healthcare
  • Bio Pharm Inc.
  • Boca Pharmacal
  • Bradley Pharmaceuticals Inc.
  • Breckenridge Pharmaceuticals
  • Brighton Pharmaceuticals
  • Bryant Ranch Prepack
  • BTA Pharmaceuticals
  • Capellon Pharmaceuticals LLC
  • Caraco Pharmaceutical Labs
  • Cardinal Health
  • Carwin Associates Inc.
  • Centurion Labs
  • Century Pharmaceuticals Inc.
  • Chemins Co. Inc.
  • Co Med Pharmaceuticals Inc.
  • Contract Pharm
  • CVS Pharmacy
  • Cypress Pharmaceutical Inc.
  • Dartmouth Pharmaceuticals Inc.
  • Deliz Pharmaceutical Corp.
  • Deltex Pharmaceuticals Inc.
  • Dental Essentials Inc.
  • Deston Therapeutics
  • Direct Dispensing Inc.
  • Dispensing Solutions
  • Diversified Healthcare Services Inc.
  • Duramed
  • Econolab Inc.
  • Elge Inc.
  • Emrex Economed Pharmaceuticals Inc.
  • Ethex Corp.
  • Everett Laboratories Inc.
  • Generics Puerto Rico Inc.
  • Gm Pharmaceuticals Inc.
  • Great Southern Laboratories
  • Hawthorn Pharmaceuticals
  • Health Care Products
  • Heartland Repack Services LLC
  • Hi Tech Pharmacal Co. Inc.
  • Iopharm Laboratories Inc.
  • Ivax Pharmaceuticals
  • Jaymac Pharmaceuticals LLC
  • Kaiser Foundation Hospital
  • Kiel Laboratories Inc.
  • KV Pharmaceutical Co.
  • Kylemore Pharmaceuticals
  • Lark Pharmaceuticals Inc.
  • Larken Laboratories Inc.
  • Liberty Pharmaceuticals
  • Llorens Pharmaceutical
  • Major Pharmaceuticals
  • Marnel Pharmaceuticals Inc.
  • MCR American Pharmaceuticals Inc.
  • Meda AB
  • Murfreesboro Pharmaceutical Nursing Supply
  • Neilgen Pharma Inc.
  • Nexgen Pharma Inc.
  • Norega Laboratories Inc.
  • Nucare Pharmaceuticals Inc.
  • Pack Pharmaceuticals
  • Palmetto Pharmaceuticals Inc.
  • Pamlab LLC
  • Patheon Inc.
  • PD-Rx Pharmaceuticals Inc.
  • Pegasus Laboratories Inc.
  • Pharma Medica Research Inc.
  • Pharmaceutical Association
  • Pharmaceutical Packaging Center
  • Pharmaceutical Utilization Management Program VA Inc.
  • Pharmedix
  • Physicians Total Care Inc.
  • Poly Pharmaceuticals Inc.
  • Portal Inc.
  • Prasco Labs
  • PRD Health Care
  • Preferred Pharmaceuticals Inc.
  • Prepak Systems Inc.
  • Provident Pharmaceuticals LLC
  • Qualitest
  • Quality Care
  • RA McNeil Co.
  • Rebel Distributors Corp.
  • Reckitt Benckiser Inc.
  • Remedy Repack
  • Resource Optimization and Innovation LLC
  • Respa Pharmaceuticals Inc.
  • Rij Pharmaceutical Corp.
  • River's Edge Pharmaceuticals
  • Sage Pharmaceuticals Inc.
  • Savage Labs
  • Scientific Laboratories Inc.
  • Scot-Tussin Lab
  • Seatrace Pharmaceuticals Inc.
  • Select Brand
  • Seyer Pharmatec Inc.
  • Silarx Pharmaceuticals
  • SJ Pharmaceuticals LLC
  • Southwood Pharmaceuticals
  • Stewart Jackson Pharmacal Inc.
  • Superior Pharmeceuticals
  • Teamm Pharmaceuticals Inc.
  • Teral Laboratories
  • Teva Pharmaceutical Industries Ltd.
  • TG United Inc.
  • Tri Med Laboratories Inc.
  • Unigen Pharmaceuticals
  • United Research Laboratories Inc.
  • Vindex Pharmaceuticals Inc.
  • Vintage Pharmaceuticals Inc.
  • Walgreen Co.
  • Weeks & Leo Co.
  • Wockhardt Ltd.
  • Wyeth Pharmaceuticals
  • Zyber Pharmaceuticals
Dosage forms
TabletOral200 mg
Suspension / dropsOral
Tablet, multilayerOral
LiquidOral100 mg/5mL
LiquidOral100 mg
SolutionOral100 mg/5mL
Tablet, coatedOral
Capsule; kitOral
Capsule, liquid filledOral
Tablet, film coatedOral
Kit97.5 mg/1
LiquidOral200 mg/5mL
Tablet, extended releaseOral
TabletOral100 mg/1
SyrupOral100 mg
LiquidOral200 mg
TabletOral400 mg
Kit; tabletOral
Solution / dropsNasal
Solution / dropsOral
SolutionOral300 mg/15mL
TabletOral1000 mg/1
TabletOral1200 mg/1
TabletOral200 mg/1
TabletOral600 mg/1
SyrupOral100 mg/5mL
SolutionOral200 mg/10mL
Tablet, orally disintegratingOral100 mg/1
SyrupOral20 mg
LiquidOral20 mg
LiquidOral5 g/100mL
SyrupOral50 mg/5mL
GranuleOral100 mg/1
Tablet, extended releaseOral600 mg/1
Tablet, multilayer, extended releaseOral600 mg
GranuleOral50 mg/1
SolutionOral100 mg
Tablet, extended releaseOral1200 mg/1
Tablet, coatedOral400 mg/1
Tablet, film coatedOral400 mg/1
Capsule, coatedOral
SyrupOral200 mg/5mL
TabletOral400 mg/1
SyrupOral200 mg
TabletOral750 mg/1
Capsule, gelatin coatedOral
LiquidOral200 mg/10mL
SyrupOral200 mg/10mL
Powder, for solutionOral
LiquidOral100 mg/6.25mL
LiquidOral200 mg/15mL
Unit descriptionCostUnit
Diabetic Tussin Max St 10-200 mg/5ml Liquid 118ml Bottle15.99USD bottle
Naldecon Senior EX 200 mg/5ml Syrup 118ml Bottle15.99USD bottle
P-ephed w/guaifen tablet1.21USD tablet
P-ephedrine-guaifen la tablet1.14USD tablet
Guaifen/p-ephed tablet sa1.01USD tablet
Organidin nr 200 mg tablet0.89USD tablet
Mucinex dm er 1200-60 mg tablet0.8USD tablet
Pseudoephedrine-guaifen tr tablet0.76USD tablet
Humibid e 400 mg tablet0.74USD tablet
Mucinex d er tablet0.73USD tablet
P-ephed w/guaifen tablet sr0.67USD tablet
Pseudoephedrine-guaif sr tablet0.63USD tablet
Guaifenesin/p-ephedrine tablet0.62USD tablet
P-ephed-guaifen tablet la0.6USD tablet
Kid's mucinex mini-melts pack0.57USD each
Mucinex cough mini-melt pack0.57USD each
Mucinex d tablet0.54USD tablet
Organidin NR 100 mg/5ml Liquid0.49USD ml
Codeine 10 mg-guai 300 mg liq0.46USD ml
Mucinex er 600 mg tablet0.44USD tablet
Mucinex 600 mg tablet0.42USD tablet
Mucinex full force nasal spray0.42USD ml
Mucinex moisture smart nas spr0.42USD ml
Tussi-Organidin NR 300-10 mg/5ml Liquid0.39USD ml
Mucus relief 400 mg tablet0.37USD tablet
Codeine-guaifen 10 mg-200 mg liq0.28USD ml
Guaifenesin 200 mg tablet0.28USD tablet
Guaifenesin-dm 400-20 mg tablet0.25USD tablet
Robitussin coughgels0.25USD each
Diabetic tussin ex 400 tablet0.2USD tablet
G-fenesin dm 20-400 mg caplet0.2USD caplet
Organ-i nr 200 mg tablet0.2USD tablet
G-fenesin 400 mg caplet0.19USD caplet
Guaifenesin 400 mg tablet0.16USD tablet
Chest congestion relief tablet0.15USD tablet
Guaifen p-ephed caplet er0.15USD caplet
Fenesin dm ir tablet0.13USD tablet
Fenesin pe ir tablet0.13USD tablet
Guaifenesin nr liquid0.13USD ml
Fenesin ir 400 mg tablet0.1USD tablet
Guaifenesin-dm nr liquid0.1USD ml
Guaifenesin-DM 100-10 mg/5ml Liquid0.09USD ml
Robitussin dm to go liquid0.09USD ml
Guaiacol liquid purified0.08USD ml
Guaifenesin dac oral solution0.08USD ml
Guaifenesin nr 100 mg/5 ml0.08USD ml
Children's mucinex cough liq0.06USD ml
Mucinex cold liquid0.06USD ml
Naldecon-dx senior0.06USD ml
Child's mucinex 100 mg/5 ml lq0.05USD ml
Guiatuss-dm syrup0.05USD ml
Adlt robitussin cough-cold-flu0.04USD ml
Adt robitussin cough-cold d lq0.04USD ml
Adult robitussin cough syrup0.04USD ml
Guiatuss DAC 30-10-100 mg/5ml Solution0.04USD ml
Robitussin chest congest syrup0.04USD ml
Robitussin cough & cold liquid0.04USD ml
Robitussin cough-cold liquid0.04USD ml
Robitussin cough-cong syrup0.04USD ml
Robitussin dm max liquid0.04USD ml
Robitussin long-acting liq0.04USD ml
Robitussin pe head & chest liq0.04USD ml
Robitussin-cough-chest-cong lq0.04USD ml
Robitussin-dm cough syrup0.04USD ml
Scot-tussin 100 mg/5 ml liq0.04USD ml
Guiatuss ac syrup0.03USD ml
Guiatuss-dac syrup0.03USD ml
Sb cough control syrup0.03USD ml
Guaifenesin ac cough syrup0.02USD ml
Guaifenesin dm syrup0.02USD ml
Guiatuss dm syrup0.02USD ml
Guiatuss-pe syrup0.02USD ml
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.
Patent NumberPediatric ExtensionApprovedExpires (estimated)


Experimental Properties
melting point (°C)78.5-79British Patent 628,497.
boiling point (°C)215 °C at 1.90E+01 mm HgPhysProp
water solubility5E+004 mg/L (at 25 °C)MERCK INDEX (1996)
Predicted Properties
Water Solubility14.9 mg/mLALOGPS
pKa (Strongest Acidic)13.62ChemAxon
pKa (Strongest Basic)-3ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area58.92 Å2ChemAxon
Rotatable Bond Count5ChemAxon
Refractivity51.24 m3·mol-1ChemAxon
Polarizability20.59 Å3ChemAxon
Number of Rings1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Human Intestinal Absorption+0.9231
Blood Brain Barrier-0.8631
Caco-2 permeable-0.6755
P-glycoprotein substrateSubstrate0.5523
P-glycoprotein inhibitor INon-inhibitor0.7979
P-glycoprotein inhibitor IINon-inhibitor0.9002
Renal organic cation transporterNon-inhibitor0.88
CYP450 2C9 substrateNon-substrate0.8348
CYP450 2D6 substrateNon-substrate0.8535
CYP450 3A4 substrateNon-substrate0.6853
CYP450 1A2 substrateInhibitor0.6013
CYP450 2C9 inhibitorNon-inhibitor0.9592
CYP450 2D6 inhibitorNon-inhibitor0.9616
CYP450 2C19 inhibitorNon-inhibitor0.9328
CYP450 3A4 inhibitorNon-inhibitor0.9481
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9445
Ames testNon AMES toxic0.7677
BiodegradationReady biodegradable0.7769
Rat acute toxicity2.0868 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9171
hERG inhibition (predictor II)Non-inhibitor0.8735
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)


Mass Spec (NIST)
Download (7.98 KB)
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Mass Spectrum (Electron Ionization)MSsplash10-00di-3900000000-022756bf476e39b7c0be
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available
LC-MS/MS Spectrum - LC-ESI-qTof , PositiveLC-MS/MSNot Available
MS/MS Spectrum - , positiveLC-MS/MSsplash10-0hb9-2900000000-261d308d57fa6814ad4e
1H NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable


This compound belongs to the class of organic compounds known as anisoles. These are organic compounds containing a methoxybenzene or a derivative thereof.
Organic compounds
Super Class
Phenol ethers
Sub Class
Direct Parent
Alternative Parents
Phenoxy compounds / Methoxybenzenes / Alkyl aryl ethers / Secondary alcohols / 1,2-diols / Primary alcohols / Hydrocarbon derivatives
Phenoxy compound / Methoxybenzene / Anisole / Alkyl aryl ether / Monocyclic benzene moiety / Secondary alcohol / 1,2-diol / Ether / Organic oxygen compound / Hydrocarbon derivative
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
Not Available

Drug created on June 13, 2005 07:24 / Updated on April 23, 2019 12:19